Maintenance Therapy with Olaparib or Selumetinib Plus Durvalumab (S+D) According to Genetic Profile of Metastatic Pancreatic Adenocarcinoma (M-Pdac) Controlled with Modified FOLFIRINOX (mffx): A Phase II Randomized MAZEPPA GERCOR D19-02 PRODIGE-72 Study.
JOURNAL OF CLINICAL ONCOLOGY（2024）
Key words
Metastatic Pancreatic Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined